Finance entity
earnings is the sole category represented across all 1 tracked stories. OneSpaWorld is most often covered alongside Celanese, which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.7 for the broader beat in this window.
Last mentioned: Feb 19, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. OneSpaWorld is most often covered alongside Celanese, which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.7 for the broader beat in this window. At 6, the average consequence score sits above the same-window beat average of 5.8. OneSpaWorld appears in 1 tracked Finance story from February 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 174 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering OneSpaWorld. Shared-story counts are live from our verified record — not editorial picks.
A wave of earnings reports from Halozyme Therapeutics, Celanese, and OneSpaWorld has revealed significant bottom-line misses, highlighting growing cost pressures and demand volatility. While Halozyme managed a revenue beat, its massive EPS shortfall points to substantial operational or one-time headwinds that are rattling investor confidence.
OneSpaWorld is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
